The drug "Fermatron", the description of which is given in the instructions for use, is a viscoelastic drug. The medication is used for injection, which is performed in the synovial space of the joints. The drug is prescribed for the treatment of osteoarthritis of large joints. The release of this product containing the substance hyaluronan, similar to natural human, is possible thanks to new modern synthesis and purification technologies.
The drug "Fermatron": reviews and instructions for use
The drug restores the viscoelastic properties of joints and the protective function of intraarticular fluid. According to therapists, injections reduce inflammation in the joints, increase their mobility, reduce pain, restore homeostasis in the cartilage, and also actively stimulate the reproduction of hyaluronic acid. The medicine "Fermatron" is used for post-traumatic and degenerative osteoarthritis of large joints.
The composition and release form of the drug "Fermatron"
Reviews and instructions indicate that the medicine is in the form of a sterile clear solution with a mass fraction of the active substance of 1 percent, which is used for injection into the inner part of the joint. The product is contained inside ready-to-use syringes with a volume of 2 ml.
Due to its properties, the drug restores hyaluronan, which is damaged by degenerative changes or joint injuries.
The work of the drug is primarily due to the physico-mechanical properties, as well as the biochemical compatibility of the drug with the human body. The tool contains polysaccharides having a high molecular weight equivalent to natural human. This polysaccharide contains gluconic acid and repeating disaccharide residues of n-acetylglucosamine, of which synovial joint fluid is practically composed.
The substance hyaluronan contained in the medicine lubricates the joint during lateral loads and performs the function of amortization with direct burden. In addition, hyaluronan has a stimulating effect on synovia cells and performs the work of a filter, delaying potentially dangerous cells and molecules of cartilage.
When using the drug "Fermatron" (pharmacists say) the effect is directly on the cause of the onset and progression of arthrosis. The medication restores the visco-elastic and protective properties of joint fluid , reduces inflammation, protects cartilage, restores homeostasis, and stimulates the production of hyaluronan. The drug eliminates the stiffness of the knee and other large joints, reduces pain.
During therapy with Fermatron, reviews and clinical studies show that a noticeable and sufficient result can be achieved after four injections, the effect of the treatment remains for six months after the last injection. For ease of use, the medicine is produced in disposable syringes, the special design of which allows for the most effective injection into the joint, while greatly reducing the risk of infection.
Contraindications for the use of the drug "Fermatron"
Reviews of doctors indicate the inadmissibility of the use of the drug with hypersensitivity to the components of the drug. Do not use the injection for wounds, infected abrasions, skin diseases at the injection site. Contraindications include acute synovitis, in which dilution of the drug with synovial fluid is possible and, as a result, the lack of a therapeutic effect. It is not recommended to administer the drug to children.